Abstract |
Preclinical studies demonstrate that pro-inflammatory cytokines increase serotonin transporter availability and function, leading to depressive symptoms in rodent models. Herein we investigate associations between circulating inflammatory markers and brainstem serotonin transporter (5-HTT) availability in humans. We hypothesised that higher circulating inflammatory cytokine concentrations, particularly of tumour necrosis factor (TNF-α), would be associated with greater 5-HTT availability, and that TNF-α inhibition with etanercept (sTNFR:Fc) would in turn reduce 5-HTT availability. In 13 neurologically healthy adult women, plasma TNF-α correlated significantly with 5-HTT availability (rho=0.6; p=0.03) determined by [(123)I]- beta-CIT SPECT scanning. This association was replicated in an independent sample of 12 patients with psoriasis/ psoriatic arthritis (rho=0.76; p=0.003). Indirect effects analysis, showed that there was a significant overlap in the variance explained by 5-HTT availability and TNF-α concentrations on BDI scores. Treatment with etanercept for 6-8weeks was associated with a significant reduction in 5-HTT availability (Z=2.09; p=0.03; r=0.6) consistent with a functional link. Our findings confirm an association between TNF-α and 5-HTT in both the basal physiological and pathological condition. Modulation of both TNF-α and 5-HTT by etanercept indicate the presence of a mechanistic pathway whereby circulating inflammatory cytokines are related to central nervous system substrates underlying major depression.
|
Authors | Rajeev Krishnadas, Alice Nicol, Jen Sassarini, Navesh Puri, A David Burden, Joyce Leman, Emilie Combet, Sally Pimlott, Donald Hadley, Iain B McInnes, Jonathan Cavanagh |
Journal | Brain, behavior, and immunity
(Brain Behav Immun)
Vol. 51
Pg. 29-38
(Jan 2016)
ISSN: 1090-2139 [Electronic] Netherlands |
PMID | 26255693
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- SLC6A4 protein, human
- Serotonin Plasma Membrane Transport Proteins
- Tumor Necrosis Factor-alpha
- Etanercept
|
Topics |
- Arthritis, Psoriatic
(diagnostic imaging, metabolism)
- Brain Stem
(diagnostic imaging, metabolism)
- Depression
(metabolism)
- Etanercept
(administration & dosage)
- Female
- Humans
- Middle Aged
- Serotonin Plasma Membrane Transport Proteins
(metabolism)
- Tomography, Emission-Computed, Single-Photon
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors, blood)
|